Characterization of the Long-Term Efficacy and Safety of Duvelisib Monotherapy in Patients with Relapsed/Refractory CLL/SLL on Treatment for > 2 Years across 4 Clinical Studies
| Autor: | Flinn, Ian W., Montillo, Marco, Nagy, Zsolt *, Gasztonyi, Zoltán *, Davids, Matthew S., Geissler, Klaus *, Rifon Roca, Jose J. *, Berkhan, Leanne *, Offner, Fritz, Le, NgocDiep *, Lustgarten, Stephanie *, Delgado, Julio |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:3146-3146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|